The importance of the adrenergic beta -blockers with structure of (S) 1-ary
loxy-3-amino-2-propanol in the treatment of different diseases has led the
development of a variety of stereoselective synthetic methodologies for thi
s stereoisomer. In this review we present several methodologies to obtain t
his compound using (i) chiral substrates, (ii) chiral catalysts (organometa
llic or enzymes) and (iii) preparative chiral chromatography, showing the a
dvantages and disadvantages of each methodology.